"10.1371_journal.pone.0151910","plos one","2016-03-31T00:00:00Z","Arto Y Strandberg; Fabian J Hoti; Timo E Strandberg; Solomon Christopher; Jari Haukka; Pasi Korhonen","University of Helsinki, Clinicum, Helsinki, Finland; Aava Medical Centre, Kerava, Finland; EPID Research, Espoo, Finland; Helsinki University Central Hospital, Helsinki, Finland; University of Oulu, Center for Life Course Health Research, Oulu, Finland","Conceived and designed the experiments: AYS FJH SC JH PK. Performed the experiments: AYS FJH TES SC JH PK. Analyzed the data: AYS FJH TES SC JH PK. Contributed reagents/materials/analysis tools: AYS FJH SC JH PK. Wrote the paper: AYS FJH TES SC JH PK. Administrative, technical, and material support: AYS FJH TES SC JH PK.","All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare that FH, SC, JH and PK are employed by EPID Research, which is a contract research organization that performs commissioned pharmacoepidemiological studies. Its employees have been and currently are working in collaboration with several pharmaceutical companies. TES has had research, educational and consultative cooperation with several pharmaceutical companies (including Novo Nordisk and Sanofi) and owns a minor amount of stock in Orion Pharma. AYS has had research, educational and consultative cooperation with several pharmaceutical companies (including Novo Nordisk and Sanofi), and owns a minor amount of stock in Orion Pharma. There are no patents, products in development, or marked products to declare. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2016","03","Arto Y Strandberg","AYS",6,TRUE,5,6,6,6,TRUE,TRUE,FALSE,0,NA,FALSE
